심막 패치 시장(제품 유형별 : 자가 이식, 이종이식, 합성/애플리케이션별 : 심장혈관 외과, 치과 외과, 안과, 기타) : 세계 산업 분석, 규모, 점유율, 성장률, 동향, 예측(2022-2031년)

The report provides revenue of the global pericardial patches market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pericardial patches market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the pericardial patches market.

The report delves into the competitive landscape of the global pericardial patches market. Key players operating in the global pericardial patches market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global pericardial patches market profiled in this report.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pericardial Patches Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
  • 4.1.2. Industry Evolution / Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Pericardial Patches Market Analysis and Forecast, 2017-2031
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Overview of Pericardial Patches Market
• 5.2. Technology advancements
• 5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
• 5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Pericardial Patches Market Analysis and Forecast, by Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast, by Product Type, 2017-2031
  • 6.3.1. Autologous
  • 6.3.2. Xenograft
    • 6.3.2.1. Bovine
    • 6.3.2.2. Porcine
    • 6.3.2.3. Equine
  • 6.3.3. Synthetic
• 6.4. Market Attractiveness Analysis, by Product Type

7. Global Pericardial Patches Market Analysis and Forecast, by Application

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast, by Application, 2017-2031
  • 7.3.1. Cardiovascular Surgery
  • 7.3.2. Dental Surgery
  • 7.3.3. Ophthalmology
  • 7.3.4. Others
• 7.4. Market Attractiveness Analysis, by Application

8. Global Pericardial Patches Market Analysis and Forecast, by End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast, by End-user, 2017-2031
  • 8.3.1. Hospitals
  • 8.3.2. Ambulatory Surgical Centers
  • 8.3.3. Others
• 8.4. Market Attractiveness Analysis, by End-user

9. Global Pericardial Patches Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value Forecast, by Region
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness Analysis, by Region

10. North America Pericardial Patches Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Product Type, 2017-2031
  • 10.2.1. Autologous
  • 10.2.2. Xenograft
    • 10.2.2.1. Bovine
    • 10.2.2.2. Porcine
    • 10.2.2.3. Equine
  • 10.2.3. Synthetic
• 10.3. Market Value Forecast, by Application, 2017-2031
  • 10.3.1. Cardiovascular Surgery
  • 10.3.2. Dental Surgery
  • 10.3.3. Ophthalmology
  • 10.3.4. Others
• 10.4. Market Value Forecast, by End-user, 2017-2031
  • 10.4.1. Hospitals
  • 10.4.2. Ambulatory Surgical Centers
  • 10.4.3. Others
• 10.5. Market Value Forecast, by Country, 2017-2031
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Product Type
  • 10.6.2. By Application
  • 10.6.3. By End-user
  • 10.6.4. By Country

11. Europe Pericardial Patches Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product Type, 2017-2031
  • 11.2.1. Autologous
  • 11.2.2. Xenograft
    • 11.2.2.1. Bovine
    • 11.2.2.2. Porcine
    • 11.2.2.3. Equine
  • 11.2.3. Synthetic
• 11.3. Market Value Forecast, by Application, 2017-2031
  • 11.3.1. Cardiovascular Surgery
  • 11.3.2. Dental Surgery
  • 11.3.3. Ophthalmology
  • 11.3.4. Others
• 11.4. Market Value Forecast, by End-user, 2017-2031
  • 11.4.1. Hospitals
  • 11.4.2. Ambulatory Surgical Centers
  • 11.4.3. Others
• 11.5. Market Value Forecast, by Country/Sub-Region, 2017-2031
  • 11.5.1. Germany
  • 11.5.2. U.K.
  • 11.5.3. France
  • 11.5.4. Spain
  • 11.5.5. Italy
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Product Type
  • 11.6.2. By Application
  • 11.6.3. By End-user
  • 11.6.4. By Country/Sub-Region

12. Asia Pacific Pericardial Patches Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product Type, 2017-2031
  • 12.2.1. Autologous
  • 12.2.2. Xenograft
    • 12.2.2.1. Bovine
    • 12.2.2.2. Porcine
    • 12.2.2.3. Equine
  • 12.2.3. Synthetic
• 12.3. Market Value Forecast, by Application, 2017-2031
  • 12.3.1. Cardiovascular Surgery
  • 12.3.2. Dental Surgery
  • 12.3.3. Ophthalmology
  • 12.3.4. Others
• 12.4. Market Value Forecast, by End-user, 2017-2031
  • 12.4.1. Hospitals
  • 12.4.2. Ambulatory Surgical Centers
  • 12.4.3. Others
• 12.5. Market Value Forecast, by Country/Sub-Region, 2017-2031
  • 12.5.1. China
  • 12.5.2. Japan
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Product Type
  • 12.6.2. By Application
  • 12.6.3. By End-user
  • 12.6.4. By Country/Sub-Region

13. Latin America Pericardial Patches Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product Type, 2017-2031
  • 13.2.1. Autologous
  • 13.2.2. Xenograft
    • 13.2.2.1. Bovine
    • 13.2.2.2. Porcine
    • 13.2.2.3. Equine
  • 13.2.3. Synthetic
• 13.3. Market Value Forecast, by Application, 2017-2031
  • 13.3.1. Cardiovascular Surgery
  • 13.3.2. Dental Surgery
  • 13.3.3. Ophthalmology
  • 13.3.4. Others
• 13.4. Market Value Forecast, by End-user, 2017-2031
  • 13.4.1. Hospitals
  • 13.4.2. Ambulatory Surgical Centers
  • 13.4.3. Others
• 13.5. Market Value Forecast, by Country/Sub-Region, 2017-2031
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Product Type
  • 13.6.2. By Application
  • 13.6.3. By End-user
  • 13.6.4. By Country/Sub-Region

14. Middle East & Africa Pericardial Patches Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Product Type, 2017-2031
  • 14.2.1. Autologous
  • 14.2.2. Xenograft
    • 14.2.2.1. Bovine
    • 14.2.2.2. Porcine
    • 14.2.2.3. Equine
  • 14.2.3. Synthetic
• 14.3. Market Value Forecast, by Application, 2017-2031
  • 14.3.1. Cardiovascular Surgery
  • 14.3.2. Dental Surgery
  • 14.3.3. Ophthalmology
  • 14.3.4. Others
• 14.4. Market Value Forecast, by End-user, 2017-2031
  • 14.4.1. Hospitals
  • 14.4.2. Ambulatory Surgical Centers
  • 14.4.3. Others
• 14.5. Market Value Forecast, by Country/Sub-Region, 2017-2031
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Product Type
  • 14.6.2. By Application
  • 14.6.3. By End-user
  • 14.6.4. By Country/Sub-Region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (by tier and size of companies)
• 15.2. Company Profiles
  • 15.2.1. Edwards Lifesciences Corporation
    • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.1.2. Product Portfolio
    • 15.2.1.3. Financial Overview
    • 15.2.1.4. SWOT Analysis
    • 15.2.1.5. Strategic Overview
  • 15.2.2. Abbott
    • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.2.2. Product Portfolio
    • 15.2.2.3. Financial Overview
    • 15.2.2.4. SWOT Analysis
    • 15.2.2.5. Strategic Overview
  • 15.2.3. Baxter International
    • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.3.2. Product Portfolio
    • 15.2.3.3. Financial Overview
    • 15.2.3.4. SWOT Analysis
    • 15.2.3.5. Strategic Overview
  • 15.2.4. Visionary medtech solutions
    • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.4.2. Product Portfolio
    • 15.2.4.3. Financial Overview
    • 15.2.4.4. SWOT Analysis
    • 15.2.4.5. Strategic Overview
  • 15.2.5. CryoLife, Inc.
    • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.5.2. Product Portfolio
    • 15.2.5.3. Financial Overview
    • 15.2.5.4. SWOT Analysis
    • 15.2.5.5. Strategic Overview
  • 15.2.6. LeMaitre Vascular, Inc.
    • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.6.2. Product Portfolio
    • 15.2.6.3. Financial Overview
    • 15.2.6.4. SWOT Analysis
    • 15.2.6.5. Strategic Overview
  • 15.2.7. Neovasc Inc.
    • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.7.2. Product Portfolio
    • 15.2.7.3. Financial Overview
    • 15.2.7.4. SWOT Analysis
    • 15.2.7.5. Strategic Overview
  • 15.2.8. FOC Medical
    • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.8.2. Product Portfolio
    • 15.2.8.3. Financial Overview
    • 15.2.8.4. SWOT Analysis
    • 15.2.8.5. Strategic Overview
  • 15.2.9. W. L. Gore & Associates, Inc.
    • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.9.2. Product Portfolio
    • 15.2.9.3. Financial Overview
    • 15.2.9.4. SWOT Analysis
    • 15.2.9.5. Strategic Overview
  • 15.2.10. Collagen Solutions Plc
    • 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.2.10.2. Product Portfolio
    • 15.2.10.3. Financial Overview
    • 15.2.10.4. SWOT Analysis
    • 15.2.10.5. Strategic Overvie